150 related articles for article (PubMed ID: 28938850)
1. CD73 expression in lymph node metastases in patients with head and neck cancer.
Mandapathil M; Boduc M; Netzer C; Güldner C; Roessler M; Wallicek-Dworschak U; Jahns E; Stuck B
Acta Otolaryngol; 2018 Feb; 138(2):180-184. PubMed ID: 28938850
[TBL] [Abstract][Full Text] [Related]
2. Foxp3 expression in lymph node metastases in patients with head and neck cancer.
Boduc M; Roessler M; Mandic R; Netzer C; Güldner C; Walliczek-Dworschak U; Stuck BA; Mandapathil M
Acta Otolaryngol; 2017 Nov; 137(11):1215-1219. PubMed ID: 28741409
[TBL] [Abstract][Full Text] [Related]
3. Ectonucleotidase CD39 expression in regional metastases in head and neck cancer.
Mandapathil M; Boduc M; Roessler M; Güldner C; Walliczek-Dworschak U; Mandic R
Acta Otolaryngol; 2018 Apr; 138(4):428-432. PubMed ID: 29172836
[TBL] [Abstract][Full Text] [Related]
4. CD73 is associated with poor prognosis in HNSCC.
Ren ZH; Lin CZ; Cao W; Yang R; Lu W; Liu ZQ; Chen YM; Yang X; Tian Z; Wang LZ; Li J; Wang X; Chen WT; Ji T; Zhang CP
Oncotarget; 2016 Sep; 7(38):61690-61702. PubMed ID: 27557512
[TBL] [Abstract][Full Text] [Related]
5. Specific blockade CD73 alters the "exhausted" phenotype of T cells in head and neck squamous cell carcinoma.
Deng WW; Li YC; Ma SR; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
Int J Cancer; 2018 Sep; 143(6):1494-1504. PubMed ID: 29663369
[TBL] [Abstract][Full Text] [Related]
6. MiR-422a promotes loco-regional recurrence by targeting NT5E/CD73 in head and neck squamous cell carcinoma.
Bonnin N; Armandy E; Carras J; Ferrandon S; Battiston-Montagne P; Aubry M; Guihard S; Meyronet D; Foy JP; Saintigny P; Ledrappier S; Jung A; Rimokh R; Rodriguez-Lafrasse C; Poncet D
Oncotarget; 2016 Jul; 7(28):44023-44038. PubMed ID: 27281619
[TBL] [Abstract][Full Text] [Related]
7. Blockade of adenosine A2A receptor enhances CD8
Ma SR; Deng WW; Liu JF; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
Mol Cancer; 2017 Jun; 16(1):99. PubMed ID: 28592285
[TBL] [Abstract][Full Text] [Related]
8. The use of an immunohistochemical diagnostic panel to determine the primary site of cervical lymph node metastases of occult squamous cell carcinoma.
Park JM; Jung CK; Choi YJ; Lee KY; Kang JH; Kim MS; Hu HJ
Hum Pathol; 2010 Mar; 41(3):431-7. PubMed ID: 19954817
[TBL] [Abstract][Full Text] [Related]
9. Strong immunohistochemical expression of vascular endothelial growth factor predicts overall survival in head and neck squamous cell carcinoma.
Tse GM; Chan AW; Yu KH; King AD; Wong KT; Chen GG; Tsang RK; Chan AB
Ann Surg Oncol; 2007 Dec; 14(12):3558-65. PubMed ID: 17929099
[TBL] [Abstract][Full Text] [Related]
10. Aberrant Myosin 1b Expression Promotes Cell Migration and Lymph Node Metastasis of HNSCC.
Ohmura G; Tsujikawa T; Yaguchi T; Kawamura N; Mikami S; Sugiyama J; Nakamura K; Kobayashi A; Iwata T; Nakano H; Shimada T; Hisa Y; Kawakami Y
Mol Cancer Res; 2015 Apr; 13(4):721-31. PubMed ID: 25421751
[TBL] [Abstract][Full Text] [Related]
11. The expression of activin receptor-like kinase 1 among patients with head and neck cancer.
Chien CY; Chuang HC; Chen CH; Fang FM; Chen WC; Huang CC; Huang HY
Otolaryngol Head Neck Surg; 2013 Jun; 148(6):965-73. PubMed ID: 23447486
[TBL] [Abstract][Full Text] [Related]
12. Distant metastases in head and neck carcinoma: identification of prognostic groups with MR imaging.
Ljumanovic R; Langendijk JA; Hoekstra OS; Leemans CR; Castelijns JA
Eur J Radiol; 2006 Oct; 60(1):58-66. PubMed ID: 16829010
[TBL] [Abstract][Full Text] [Related]
13. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
[TBL] [Abstract][Full Text] [Related]
14. Activity of ecto-5'-nucleotidase (NT5E/CD73) is increased in papillary thyroid carcinoma and its expression is associated with metastatic lymph nodes.
Bertoni APS; Bracco PA; de Campos RP; Lutz BS; Assis-Brasil BM; Meyer ELS; Saffi J; Braganhol E; Furlanetto TW; Wink MR
Mol Cell Endocrinol; 2019 Jan; 479():54-60. PubMed ID: 30184475
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of VEGF immunohistochemical expression and tumor angiogenesis in head and neck squamous cell carcinoma.
Kyzas PA; Stefanou D; Batistatou A; Agnantis NJ
J Cancer Res Clin Oncol; 2005 Sep; 131(9):624-30. PubMed ID: 16044346
[TBL] [Abstract][Full Text] [Related]
16. Assessment and clinical significance of micrometastases in lymph nodes of head and neck cancer patients detected by E48 (Ly-6D) quantitative reverse transcription-polymerase chain reaction.
Nieuwenhuis EJ; Leemans CR; Kummer JA; Denkers F; Snow GB; Brakenhoff RH
Lab Invest; 2003 Aug; 83(8):1233-40. PubMed ID: 12920252
[TBL] [Abstract][Full Text] [Related]
17. RhoC GTPase expression as a potential marker of lymph node metastasis in squamous cell carcinomas of the head and neck.
Kleer CG; Teknos TN; Islam M; Marcus B; Lee JS; Pan Q; Merajver SD
Clin Cancer Res; 2006 Aug; 12(15):4485-90. PubMed ID: 16899593
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical studies in the identification of lymph node micrometastases in patients with squamous cell carcinoma of the head and neck.
Rinaldo A; Devaney KO; Ferlito A
ORL J Otorhinolaryngol Relat Spec; 2004; 66(1):38-41. PubMed ID: 15103200
[TBL] [Abstract][Full Text] [Related]
19. P53 expression in squamous cell carcinomas of the supraglottic larynx and its lymph node metastases: new results for an old question.
Cabanillas R; Rodrigo JP; Astudillo A; Domínguez F; Suárez C; Chiara MD
Cancer; 2007 May; 109(9):1791-8. PubMed ID: 17380529
[TBL] [Abstract][Full Text] [Related]
20. Staging of head and neck squamous cell carcinoma using the MET oncogene product as marker of tumor cells in lymph node metastases.
Cortesina G; Martone T; Galeazzi E; Olivero M; De Stefani A; Bussi M; Valente G; Comoglio PM; Di Renzo MF
Int J Cancer; 2000 May; 89(3):286-92. PubMed ID: 10861506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
